SGB-7342

· Suzhou Sanegene Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGB-7342, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGB-7342 in Subjects With Obesity or Overweight [Phase 1]